000931 Beijing Centergate Technologies(Holding)Co.,Ltd.
Closed 04-18 15:00:00
4.99
-0.21
-4.04%
High
5.25
Low
4.88
Vol
46.87M
Open
5.16
D1 Closing
5.20
Amplitude
7.12%
Mkt Cap
3.76B
Tradable Cap
3.72B
Total Shares
753.00M
T/O
235.00M
T/O Rate
6.28%
Tradable Shares
746.00M
P/B
2.47
ROE
--
EPS
0.00
52wk High
--
52wk Low
--
P/E
--
Dividend
--
Div.Yield
--
ROA
--
Time
5D
D
W
M
Loading ...
News
New Post(s)
Profile
Chinese Drug Administration Accepts Application of Centergate Technologies' Unit for Oxycodone Hydrochloride Tablets
MT Newswires Live · 03-14
Chinese Drug Administration Accepts Application of Centergate Technologies' Unit for Oxycodone Hydrochloride Tablets
Centergate Technologies' Unit Gets Patent for Antibacterial Mouthwash Tester
MT Newswires Live · 02-14
Centergate Technologies' Unit Gets Patent for Antibacterial Mouthwash Tester
Chinese Drug Regulator Accepts Beijing Centergate Tech Unit's Evaluation Application for Tramadol Hydrochloride Tablets; Shares Up 4%
MT Newswires Live · 01-14
Chinese Drug Regulator Accepts Beijing Centergate Tech Unit's Evaluation Application for Tramadol Hydrochloride Tablets; Shares Up 4%
Chinese Drug Regulator Accepts Centergate Technologies Unit's Marketing Application for Painkillers
MT Newswires Live · 2024-12-19
Chinese Drug Regulator Accepts Centergate Technologies Unit's Marketing Application for Painkillers
Beijing Centergate Technologies Units' 34 Drugs Secure Spot on China's Insurance Drug Catalog for 2024; Shares Up 4%
MT Newswires Live · 2024-12-12
Beijing Centergate Technologies Units' 34 Drugs Secure Spot on China's Insurance Drug Catalog for 2024; Shares Up 4%
Load more
Introduction
Company Name.
北京中关村科技发展(控股)股份有限公司
Industry:
医药制造业
Listing Date:
1999-07-12
Main Business:
北京中关村科技发展(控股)股份有限公司的主营业务是生物医药及健康品业务、养老医疗业务、商砼业务和其他业务。公司的主要产品是知母皂苷BⅡ及胶囊、联苯苄唑原料药、盐酸纳洛酮注射液、盐酸纳曲酮片、氨酚羟考酮片、盐酸氨溴索注射液、盐酸曲马多注射液、非布司他片、格列吡嗪分散片、琥珀酸美托洛尔原料药。公司的西地碘含片曾获得国家技术发明二等奖、军队科技进步一等奖。盐酸苯环壬酯成分及制备方法获国家发明专利,曾获联合国世界知识产权组织授予的杰出发明奖。
Issue price:
23.49
Invest in Global Markets with Tiger Brokers!
Open App
{"stockData":{"symbol":"000931","market":"SZ","secType":"STK","nameCN":"Beijing Centergate Technologies(Holding)Co.,Ltd.","latestPrice":4.99,"timestamp":1744959786000,"preClose":5.2,"halted":0,"volume":46867243,"delay":0,"changeRate":-0.0404,"floatShares":746000000,"shares":753000000,"eps":0.0776,"marketStatus":"Closed","change":-0.21,"latestTime":"04-18 15:00:00","open":5.16,"high":5.25,"low":4.88,"amount":235000000,"amplitude":0.0712,"askPrice":5,"askSize":1847,"bidPrice":4.99,"bidSize":575,"shortable":0,"etf":0,"ttmEps":0.0776,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745199000000},"marketStatusCode":5,"adr":0,"adjPreClose":5.2,"symbolType":"stock","openAndCloseTimeList":[[1744939800000,1744947000000],[1744952400000,1744959600000]],"highLimit":5.72,"lowLimit":4.68,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":753126982,"isCdr":false,"pbRate":2.47,"roa":"--","peRate":64.304124,"roe":"3.43%","epsLYR":0.0712,"committee":0.011298,"marketValue":3758000000,"turnoverRate":0.0628,"status":1,"nextConnectDate":"Northbound have stopped. The next trading day is UTC+8 2025-04-22.","floatMarketCap":3723000000},"requestUrl":"/m/hq/s/000931","defaultTab":"news","newsList":[{"id":"2519784293","title":"Chinese Drug Administration Accepts Application of Centergate Technologies' Unit for Oxycodone Hydrochloride Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=2519784293","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519784293?lang=en_us&edition=full_marsco","pubTime":"2025-03-14 15:14","pubTimestamp":1741936498,"startTime":"0","endTime":"0","summary":"China's National Medical Products Administration accepted the application of Beijing Centergate Technologies Holding's subsidiary, Beijing Huasu Pharmaceutical, to market extended-release oxycodone hydrochloride tablets, according to a Shenzhen Stock Exchange disclosure on Thursday.The drug is used for the treatment of severe pain that requires long-term, continuous use of opioids, and when substitution therapies are not adequate to relieve the pain, the Chinese biomedicine and healthcare company said.The company's shares closed 2% higher.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["000931","SAVA","BK0028","BK0239","BK4585","BK4007","BK4588","BK4547","BK0178","BK0075"],"gpt_icon":0},{"id":"2511063937","title":"Centergate Technologies' Unit Gets Patent for Antibacterial Mouthwash Tester","url":"https://stock-news.laohu8.com/highlight/detail?id=2511063937","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511063937?lang=en_us&edition=full_marsco","pubTime":"2025-02-14 14:08","pubTimestamp":1739513297,"startTime":"0","endTime":"0","summary":"Beijing Centergate Technologies Holding's unit, Shandong Huasu Health Care Products, obtained a utility model patent certificate from the China National Intellectual Property Administration, according to a Shenzhen Stock Exchange disclosure on Thursday.The patent is for the Chinese biomedicine and healthcare company's pH tester for antibacterial mouthwash, the disclosure said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0075","BK0028","CFA.SI","BK0239","BK0178","000931"],"gpt_icon":0},{"id":"2503590344","title":"Chinese Drug Regulator Accepts Beijing Centergate Tech Unit's Evaluation Application for Tramadol Hydrochloride Tablets; Shares Up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503590344","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503590344?lang=en_us&edition=full_marsco","pubTime":"2025-01-14 13:44","pubTimestamp":1736833461,"startTime":"0","endTime":"0","summary":"The Chinese drug administration accepted the application of Beijing Centergate Technologies Holding's (SHE:000931) unit, Beijing Huasu Pharmaceutical, for the consistency evaluation of tramadol hydroc","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0075","000931","BK0178","BK0028","BK0239"],"gpt_icon":0},{"id":"2492147492","title":"Chinese Drug Regulator Accepts Centergate Technologies Unit's Marketing Application for Painkillers","url":"https://stock-news.laohu8.com/highlight/detail?id=2492147492","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492147492?lang=en_us&edition=full_marsco","pubTime":"2024-12-19 18:18","pubTimestamp":1734603539,"startTime":"0","endTime":"0","summary":"The Chinese drug administration accepted the application of Beijing Centergate Technologies Holding's unit, Beijing Huasu Pharmaceutical, to market hydrocodone acetaminophen tablets, according to a Shenzhen Stock Exchange disclosure on Wednesday.The drug is indicated for the treatment of moderate-to-severe pain, the biomedicine and personal care products manufacturer said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","000931","BK0178","BK0075","BK0028"],"gpt_icon":0},{"id":"2490208698","title":"Beijing Centergate Technologies Units' 34 Drugs Secure Spot on China's Insurance Drug Catalog for 2024; Shares Up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490208698","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490208698?lang=en_us&edition=full_marsco","pubTime":"2024-12-12 14:50","pubTimestamp":1733986225,"startTime":"0","endTime":"0","summary":"Thirty four drugs of Beijing Centergate Technologies Holding's pharmaceutical subsidiaries were included in China's National Basic Medical Insurance, Work-related Injury Insurance and Maternity Insurance Drug Catalog for 2024, according to a Shenzhen Stock Exchange filing on Wednesday.The list included bisoprolol fumarate tablets, benidipine hydrochloride tablets, oxycodone hydrochloride tablets, and naloxone hydrochloride injection, among others.Some of the drugs were already included in the 2023 catalog.The catalog for the year will be implemented on Jan. 1, 2025, the filing said.The residential and office building developer's shares jumped over 4% in recent trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","BK0028","BK0075","000931","BK0178"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1999-07-12","address":"北京市海淀区中关村南大街32号","stockEarnings":[{"period":"1week","weight":0.1138},{"period":"1month","weight":0.002},{"period":"3month","weight":0.0967},{"period":"6month","weight":0.0662},{"period":"1year","weight":0.2697},{"period":"ytd","weight":0.0483}],"companyName":"北京中关村科技发展(控股)股份有限公司","boardCode":"AI0027","perCapita":"10550股","boardName":"医药制造业","registeredCapital":"75312万元","compareEarnings":[{"period":"1week","weight":0.0119},{"period":"1month","weight":-0.0437},{"period":"3month","weight":0.0108},{"period":"6month","weight":0.0047},{"period":"1year","weight":0.0659},{"period":"ytd","weight":-0.0224}],"survey":" 北京中关村科技发展(控股)股份有限公司的主营业务是生物医药及健康品业务、养老医疗业务、商砼业务和其他业务。公司的主要产品是知母皂苷BⅡ及胶囊、联苯苄唑原料药、盐酸纳洛酮注射液、盐酸纳曲酮片、氨酚羟考酮片、盐酸氨溴索注射液、盐酸曲马多注射液、非布司他片、格列吡嗪分散片、琥珀酸美托洛尔原料药。公司的西地碘含片曾获得国家技术发明二等奖、军队科技进步一等奖。盐酸苯环壬酯成分及制备方法获国家发明专利,曾获联合国世界知识产权组织授予的杰出发明奖。","serverTime":1745073543504,"listedPrice":23.49,"stockholders":"70713人(较上一季度减少1.02%)","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Beijing Centergate Technologies(Holding)Co.,Ltd.(000931),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Beijing Centergate Technologies(Holding)Co.,Ltd.(000931) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Beijing Centergate Technologies(Holding)Co.,Ltd.,000931,Beijing Centergate Technologies(Holding)Co.,Ltd.股票,Beijing Centergate Technologies(Holding)Co.,Ltd.股票老虎,Beijing Centergate Technologies(Holding)Co.,Ltd.股票老虎国际,Beijing Centergate Technologies(Holding)Co.,Ltd.行情,Beijing Centergate Technologies(Holding)Co.,Ltd.股票行情,Beijing Centergate Technologies(Holding)Co.,Ltd.股价,Beijing Centergate Technologies(Holding)Co.,Ltd.股市,Beijing Centergate Technologies(Holding)Co.,Ltd.股票价格,Beijing Centergate Technologies(Holding)Co.,Ltd.股票交易,Beijing Centergate Technologies(Holding)Co.,Ltd.股票购买,Beijing Centergate Technologies(Holding)Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Beijing Centergate Technologies(Holding)Co.,Ltd.(000931),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Beijing Centergate Technologies(Holding)Co.,Ltd.(000931) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}